Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Mol Cancer Ther. 2012 Jan 11;11(3):639–648. doi: 10.1158/1535-7163.MCT-11-0671

Table 1.

Analysis of DNA synthesis in LS-174T tumor xenografts following treatment with 212Pb-TCMC-trastuzumab.

Time point (h)
0 6 24 48 72 96 120
None 23.8±1.3
212Pb-Trastuzumab 13.7±.2 7.3±1.4 2.6±0.7 7.5±0.5 1.1±0.2 1.6±0.3
212Pb-HuIgG 16.4±1.2 8.1±0.9 2.4±0.1 2.8±0.5 4.2±0.4 13.2±0.4
Trastuzumab 15.1±1.0 21.4±1.1 14.8±12.9 27.5±1.5 20.6±1.8 18.2±2.3
HuIgG 15.9±0.8 19.0±0.4 20.7±1.3 23.4±1.1 22.1±0.6 16.7±1.3

Results represent the average of a minimum of three replications (± SD).